Classification and differential effectiveness of goal-directed hemodynamic therapies in surgical patients: A network meta-analysis of randomized controlled trials
Zhao X, Tian L, Brackett A, Dai F, Xu J, Meng L. Classification and differential effectiveness of goal-directed hemodynamic therapies in surgical patients: A network meta-analysis of randomized controlled trials. Journal Of Critical Care 2020, 61: 152-161. PMID: 33171332, DOI: 10.1016/j.jcrc.2020.10.031.Peer-Reviewed Original ResearchMeSH KeywordsCardiac OutputGoalsHemodynamicsHumansNetwork Meta-AnalysisRandomized Controlled Trials as TopicConceptsGoal-directed hemodynamic therapyCardiac output optimizationAcute kidney injuryIntravascular volumeSurgical patientsStroke volumeHemodynamic therapyIntravascular volume optimizationStroke volume optimizationCumulative ranking curvePROSPERO registration numberAKI reductionKidney injurySystemic oxygenationCardiac outputMortality reductionOxygen deliveryRegistration numberPatientsVolume optimizationArrhythmiasTherapyMortalityOverall evidenceTrialsHemodynamic management and surgical site infection: Network meta-analysis of randomized controlled trials
Zhao X, Zhang L, Brackett A, Dai F, Xu J, Meng L. Hemodynamic management and surgical site infection: Network meta-analysis of randomized controlled trials. Journal Of Clinical Anesthesia 2020, 67: 110021. PMID: 32927235, DOI: 10.1016/j.jclinane.2020.110021.Peer-Reviewed Original ResearchMeSH KeywordsFluid TherapyHemodynamicsHumansNetwork Meta-AnalysisRandomized Controlled Trials as TopicSurgical Wound InfectionConceptsGoal-directed hemodynamic therapySurgical site infectionCardiac output optimizationSepsis/septic shockRespiratory infectious complicationsStroke volume optimizationInfectious complicationsIntravascular volumeHemodynamic managementStroke volumeUsual careSeptic shockSite infectionCumulative ranking curve (SUCRA) scoresHemodynamic management strategiesRestrictive fluid therapyUsual care groupWeb of ScienceGDHT groupHemodynamic therapySecondary outcomesSurgical patientsPrimary outcomeCare groupFluid therapyMortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis
Klemen ND, Feingold PL, Hashimoto B, Wang M, Kleyman S, Brackett A, Gross CP, Pei KY. Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis. The Lancet Haematology 2020, 7: e583-e593. PMID: 32735837, DOI: 10.1016/s2352-3026(20)30211-8.Peer-Reviewed Original ResearchMeSH KeywordsBayes TheoremHumansPrognosisRandomized Controlled Trials as TopicRisk FactorsSurvival RateVenous ThromboembolismConceptsVenous thromboembolism preventionFatal pulmonary embolismPulmonary embolismVenous thromboembolismThromboembolism preventionMajor bleedingRisk ratioMortality riskTreatment groupsControl groupSystematic reviewLess major bleedingMedian risk ratioMore pulmonary embolismDe-escalation trialsVenous thromboembolism riskStudy of patientsActive control agentWeb of ScienceAntiplatelet therapyEligible RCTsPrimary endpointSecondary endpointsComposite endpointOverall mortalityRevascularization Options for Females With Multivessel Coronary Artery Disease A Meta-Analysis of Randomized Controlled Trials
Gul B, Shah T, Head SJ, Chieffo A, Hu X, Li F, Brackett A, Gesick C, Bisarya PK, Lansky A. Revascularization Options for Females With Multivessel Coronary Artery Disease A Meta-Analysis of Randomized Controlled Trials. JACC Cardiovascular Interventions 2020, 13: 1009-1010. PMID: 32113933, DOI: 10.1016/j.jcin.2019.12.036.Peer-Reviewed Original ResearchMeSH KeywordsCoronary Artery BypassCoronary Artery DiseaseFemaleHumansPercutaneous Coronary InterventionRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsSex FactorsTreatment Outcome